Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Tsakona

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical and Laboratory Haematology|January 1, 1992
Patterns of primary degranulation as indicated by the mean myeloperoxidase index (MPXI) during bacteraemia in lymphoma transplants treated with growth factorsC P Tsakona, A H Goldstone
Bone Marrow Transplantation|June 1, 1993
Does treatment with haemopoietic growth factors affect the incidence of bacteraemia in adult lymphoma transplant recipients?C P Tsakona, A Khwaja, A H Goldstone
Acta Haematologica|January 1, 1992
Use of flow cytochemistry via the H*1 in FAB identification of acute leukaemiasC P Tsakona, S E Kinsey, A H Goldstone
Clinical and Laboratory Haematology|March 1, 1995
Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancyD P Tsakonas, K H Nicolaides, C P Tsakona, et al.
Clinical and Laboratory Haematology|December 1, 1994
Myeloperoxidase activity and nuclear segmentation of maternal neutrophils during normal pregnancyD P Tsakonas, C P Tsakona, C P Worman, et al.
British Journal of Haematology|February 1, 1994
Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLLA P Jewell, K L Yong, C P Worman, et al.
Acta Haematologica|January 1, 1993
Low-dose recombinant alfa-2a-interferon: a feasible maintenance therapy in acute myeloid leukaemia in the older patientE N McSweeney, C P Worman, C P Tsakona, et al.
British Journal of Haematology|September 1, 1993
Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemiaE N McSweeney, F J Giles, C P Worman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Laboratory Haematology|January 1, 1992
Patterns of primary degranulation as indicated by the mean myeloperoxidase index (MPXI) during bacteraemia in lymphoma transplants treated with growth factorsC P Tsakona, A H Goldstone
Bone Marrow Transplantation|June 1, 1993
Does treatment with haemopoietic growth factors affect the incidence of bacteraemia in adult lymphoma transplant recipients?C P Tsakona, A Khwaja, A H Goldstone
Acta Haematologica|January 1, 1992
Use of flow cytochemistry via the H*1 in FAB identification of acute leukaemiasC P Tsakona, S E Kinsey, A H Goldstone
Clinical and Laboratory Haematology|March 1, 1995
Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancyD P Tsakonas, K H Nicolaides, C P Tsakona, et al.
Clinical and Laboratory Haematology|December 1, 1994
Myeloperoxidase activity and nuclear segmentation of maternal neutrophils during normal pregnancyD P Tsakonas, C P Tsakona, C P Worman, et al.
British Journal of Haematology|February 1, 1994
Serum macrophage colony-stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early-stage B-CLLA P Jewell, K L Yong, C P Worman, et al.
Acta Haematologica|January 1, 1993
Low-dose recombinant alfa-2a-interferon: a feasible maintenance therapy in acute myeloid leukaemia in the older patientE N McSweeney, C P Worman, C P Tsakona, et al.
British Journal of Haematology|September 1, 1993
Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemiaE N McSweeney, F J Giles, C P Worman, et al.
Pageof 1